Stock BIO3 BIOTEST AG
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Biotest AG

Equities

BIO3

DE0005227235

Market Closed - Xetra
Other stock markets
 16:36:14 28/06/2024 BST 		5-day change 1st Jan Change
26.7 EUR +1.14% Intraday chart for Biotest AG +0.38% -13.87%
06-17 Biotest Receives FDA Approval for Innovative Yimmugo Immunoglobulin to Treat Primary Immunodeficiencies CI
05-07 Biotest Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Insiders

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Biotest AG Appoints Peter Janssen as Chairman of the Management Board, Effective from January 1, 2024
CI
Biotest Names New CFO
MT
Biotest Names Successor For Outgoing COO
MT
Biotest AG Announces Board Changes
CI
Biotest AG Appoints Jörg Schüttrumpf as Chief Scientific Officer, Effective January 1, 2022
CI
Biotest Aktiengesellschaft Proposes Preference Dividend, Payable on May 13, 2020; Proposes Resignation of Cathrin Schleussner from supervisory Board
CI
Biotest AG Announces Executive Changes, Effective May 1, 2019
CI
Shield Therapeutics plc Appoints Rolf Hoffmann as Non-Executive Director
CI
Biotest AG Announces Management Changes
CI
Biotest AG Appoints Floß to the Board of Management
CI
Biotest AG with New Management Team for Research and Regulatory Affairs
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BIO3 Stock
  4. News Biotest AG
  5. Insiders